- Home
- ATXI vs APDN Comparison
ATXI vs APDN Comparison
Compare ATXI & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXI
- APDN
- Stock Information
- Founded
- ATXI 2015
- APDN 1983
- Country
- ATXI United States
- APDN United States
- Employees
- ATXI N/A
- APDN N/A
- Industry
- ATXI Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- ATXI Health Care
- APDN Consumer Discretionary
- Exchange
- ATXI Nasdaq
- APDN Nasdaq
- Market Cap
- ATXI 3.0M
- APDN 3.3M
- IPO Year
- ATXI 2017
- APDN N/A
- Fundamental
- Price
- ATXI $1.93
- APDN $0.16
- Analyst Decision
- ATXI Strong Buy
- APDN Strong Buy
- Analyst Count
- ATXI 1
- APDN 1
- Target Price
- ATXI $56.25
- APDN $1.50
- AVG Volume (30 Days)
- ATXI 78.9K
- APDN 4.9M
- Earning Date
- ATXI 11-14-2024
- APDN 12-05-2024
- Dividend Yield
- ATXI N/A
- APDN N/A
- EPS Growth
- ATXI N/A
- APDN N/A
- EPS
- ATXI N/A
- APDN N/A
- Revenue
- ATXI N/A
- APDN $3,398,049.00
- Revenue This Year
- ATXI N/A
- APDN N/A
- Revenue Next Year
- ATXI N/A
- APDN $48.01
- P/E Ratio
- ATXI N/A
- APDN N/A
- Revenue Growth
- ATXI N/A
- APDN N/A
- 52 Week Low
- ATXI $1.60
- APDN $0.15
- 52 Week High
- ATXI $26.48
- APDN $22.80
- Technical
- Relative Strength Index (RSI)
- ATXI 38.77
- APDN 28.68
- Support Level
- ATXI $1.97
- APDN $0.17
- Resistance Level
- ATXI $2.41
- APDN $0.21
- Average True Range (ATR)
- ATXI 0.19
- APDN 0.02
- MACD
- ATXI -0.03
- APDN 0.02
- Stochastic Oscillator
- ATXI 34.02
- APDN 9.09
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.